Preface: The 2023 National Two Sessions have successfully concluded. Xinhua Network has entered enterprises, showcasing the hot practice of learning and implementing the spirit of the Two Sessions through integrated media, demonstrating the effectiveness of enterprises in leading high-quality development through innovation, demonstrating the new driving force of China's strong economic recovery, and the firm confidence of enterprises in China's economic development. "Promote the inheritance, innovation and development of traditional Chinese medicine, and benefit people's livelihood", "implement the major project of revitalizing and developing traditional Chinese medicine"... These contents in this year's Report on the Work of the Government are deeply concerned by traditional Chinese medicine enterprises. ?? Shandong Buchang Pharmaceutical Co., Ltd. (hereinafter referred to as "Buchang Pharmaceutical"), a private pharmaceutical enterprise, has always aimed to "internationalize the modern market of traditional Chinese medicine" and deeply explore the value of modern Chinese medicine in all aspects. Recently, Zhao Tao, Chairman of Buchang Pharmaceutical, told Xinhua that since its establishment, we have adhered to the development of traditional Chinese medicine as the main line, based on the modernization of traditional Chinese medicine, and taking into account biopharmaceuticals, chemical drugs, vaccines, etc. While promoting the excellent traditional culture of traditional Chinese medicine, we have continuously increased investment in product research and development, expanded our research and development fields, and assisted in the high-quality development of the pharmaceutical industry. ?? Increase R&D investment and accelerate the layout of the big health industry chain?? The Report on the Work of the Government pointed out that "promoting the inheritance, innovation and development of traditional Chinese medicine and benefiting the people's livelihood." It was reported that Pace Pharmaceuticals adhered to integrity and innovation, and promoted the layout and development of the whole industrial chain of traditional Chinese medicine, vaccines, biological medicine and chemical medicine. "After more than 20 years of development, Buchang Pharmaceutical has built a clear development strategy, focusing on common cardiovascular and cerebrovascular diseases such as stroke, arrhythmia, insufficiency of blood supply, ischemia and infarction, focusing on patented traditional Chinese patent medicines and simple preparations, and committed to the modern research, development, production, and sales of traditional Chinese medicine." said Zhao Jing, vice chairman of Buchang Pharmaceutical. ?? According to Zhao Jing, Buchang Pharmaceutical has developed and cultivated exclusive traditional Chinese medicine varieties such as Naoxintong Capsules, Wenxin Granules, and Danhong Injection based on the theory of treating both brain and heart diseases. It attaches great importance to the position of chemical and biological drugs in the field of cardiovascular and cerebrovascular diseases, and has cultivated two exclusive patent varieties of chemical drugs, namely Guhong Injection and Compound Tripeptide Injection; At the same time, it has successfully achieved product coverage in the fields of gynecology, diabetes, pediatrics, anti-tumor, urology and digestion, bone joints and respiratory system, forming a three-dimensional product pattern based on the cardiovascular and cerebrovascular market, covering the traditional advantageous fields of traditional Chinese patent medicines and simple preparations, focusing on major diseases, and cultivating large varieties. ?? Not only that, Buchang Pharmaceutical has also actively laid out the fast-moving consumer goods industry and established Buchang Supermarket Business Unit; Acquired Chongqing Yijitang Biological Products Co., Ltd., Chongqing Hantong Biotechnology Co., Ltd., Ningbo Buchang Life Technology Co., Ltd., and Zhejiang Buchang Health Technology Co., Ltd. At the same time, efforts will be made in various aspects such as channels, research and development, and products, including online drug purchasing platforms, diagnostic reagents and medical devices, early tumor functional imaging technology, and image navigation tumor minimally invasive precision diagnosis and treatment technology, to create a complete biopharmaceutical industry chain. ?? Buchang Pharmaceutical continues to focus on the research of therapeutic drugs for major diseases such as cardiovascular and cerebrovascular diseases, gynecology, etc., accumulating significant advantages in technology, products, and personnel, and emphasizing the extension of the research chain. It has established a comprehensive research system based on the theory of brain heart co treatment, covering research, project approval, small trials, pilot trials, clinical trials, and industrialization, extending to evidence-based medicine research after the drug is launched